the Image

Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or email cancerclinicaltrials@bsd.uchicago.edu .

Share this:
Brief Title A Study to Evaluate the Safety of Intramuscular Injections of PLX-R18 in Subjects With Incomplete Hematopoietic Recovery Following Hematopoietic Cell Transplantation
Official Title A Phase I Open-label Dose-escalation Study to Evaluate the Safety of Intramuscular Injections of PLX-R18 in Subjects With Incomplete Hematopoietic Recovery Following Hematopoietic Cell Transplantation
Principal Investigator Bishop, Michael
Brief Summary This study aims to evaluate the safety of intramuscular (IM) administration of PLX-R18 in subjects with incomplete hematopoietic recovery following HCT.
Gender All
Ages 18 Years
Enrollment 30
Accepts Healthy Volunteers No
Lead Sponsor Pluristem Ltd.Industry
Collaborator
Study Design
Study Phase Phase 1
Study Type Interventional
Contact Name Michael Bishop
Contact Phone 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials)
Condition Incomplete HCT (Hematopoietic Cell Transplantation)
Detail for Health Professional (on clinicaltrials.gov)
More clinical trials by this PI